You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR NIFEDIPINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for nifedipine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000102 ↗ Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets Completed National Center for Research Resources (NCRR) Phase 1/Phase 2 1969-12-31 This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).
NCT00000478 ↗ Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1990-11-01 To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.
NCT00000530 ↗ Raynaud's Treatment Study (RTS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1992-09-01 To determine the relative efficacy of usual medical care and a course of treatment by thermal biofeedback in reducing vasospastic attacks characteristic of Raynaud's syndrome. Also, to confirm the frequency and severity of attacks, examine the role of psychophysiological factors in precipitating attacks, and assess the influence of treatment on health quality of life.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for nifedipine

Condition Name

Condition Name for nifedipine
Intervention Trials
Hypertension 30
Preterm Labor 10
Hypertension in Pregnancy 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for nifedipine
Intervention Trials
Hypertension 55
Obstetric Labor, Premature 32
Premature Birth 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for nifedipine

Trials by Country

Trials by Country for nifedipine
Location Trials
United States 95
China 30
United Kingdom 22
Italy 22
Spain 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for nifedipine
Location Trials
California 10
Texas 7
Ohio 7
Tennessee 6
North Carolina 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for nifedipine

Clinical Trial Phase

Clinical Trial Phase for nifedipine
Clinical Trial Phase Trials
Phase 4 50
Phase 3 26
Phase 2/Phase 3 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for nifedipine
Clinical Trial Phase Trials
Completed 82
Unknown status 32
Recruiting 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for nifedipine

Sponsor Name

Sponsor Name for nifedipine
Sponsor Trials
Bayer 18
Assiut University 5
RDD Pharma Ltd 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for nifedipine
Sponsor Trials
Other 170
Industry 42
NIH 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.